Efficacy and safety of intravenous ulinastatin versus placebo along with standard supportive care in subjects with mild or severe acute pancreatitis

Journal of Association of Physicians of India

Volumn 61, Issue 8, 2013, Pages 15-18

  Abraham, Philip ^a   Rodriques, Jude ^b   Moulick, Nivedita ^c   Dharap, Satish ^d   Chafekar, Neelima ^e   Verma, Pradeep K ^f   Agrawal, Anil ^g   Prabhakar, Boddu ^h   Basavaraj, Anita ⁱ   Shah, Asha ^j   Chaphekar, Aniruddha P ^k   Chandra Biswal, Upendra ^l   Malhan, Sundeep T ^m   Bakshi, Girish ⁿ  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

^b GOA MEDICAL COLLEGE   (India)

^c Department of Medicine ^*  (India)

^d LOKMANYA TILAK MUNICIPAL GENERAL HOSPITAL   (India)

^e Department of Medicine   (India)

^f SAFDARJUNG HOSPITAL   (India)

^g G B PANT HOSPITAL   (India)

^h OSMANIA MEDICAL COLLEGE   (India)

ⁱ B J Govt Medical College and Sassoon General Hospital   (India)

^j CIVIL HOSPITAL   (India)

^k BYL NAIR CHARITABLE HOSPITAL   (India)

^l DR RAM MANOHAR LOHIA HOSPITAL   (India)

^m VS Hospital   (India)

ⁿ SIR J J GROUP OF HOSPITALS   (India)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881148392     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Citone G, Perri S, Nardi M Jr, et al. Efficacy of somatostatin and its analogues in the treatment of acute pancreatitis: clinical retrospective study. G Chir 2001;22:139-49.
2. Fantini L, Tomassetti P, Pezzilli R. Management of acute pancreatitis: current knowledge and future perspectives. World J Emerg Surg 2006;1:16.
3. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974;139:69-81.
4. Blamey SL, Imrie CW, O'Neill J, Gilmour WH, Carter DC. Prognostic factors in acute pancreatitis. Gut 1984;25:1340-1346.
5. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE. APACHE-Acute Physiology and Chronic Health Evaluation: a physiologically based classification system. Crit Care Med 1981;9:591-7.
6. Balthazar EJ, MD. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology 2002;223:603-13.
7. Stevens T, Parsi MA, Walsh RM. Acute pancreatitis: problems in adherence to guidelines. Cleveland Clin J Med 2009;76:697-704.
8. Han JI. Urinary trypsin inhibitor: miraculous medicine in many surgical situations? Korean J Anesthesiol 2010;58:325-7.
9. Park J, Kwak SH, Jeong CW, Bae HB, Kim SJ. Effect of ulinastatin on cytokine reaction during gastrectomy. Korean J Anesthesiol 2010;58:334-337.
10. Park KH, Lee KH, Kim H, and Hwang SO. The Anti-Inflammatory Effects of ulinastatin in trauma patients with hemorrhagic shock. J Korean Med Sci 2010;25:128-134.
11. Nishiyama T, Yokoyama T, Yamashita K. Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery. J Anesth 2006;20:179-182.
12. Yumin L, Hao C, Xun L, Wence Z, Minyan H, Chiriva-Internati M, Wachtel MS, Frezza EE. A new immunomodulatory therapy for severe sepsis: Ulinastatin Plus Thymosin {alpha} 1. J Intensive Care Med 2009;24:47-53
13. Tsujino T, Komatsu Y, Isayama H, Hirano K, Sasahira N, Yamamoto N, Toda N, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol 2005;3:376.
14. Uemura K, Murakami Y, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T. Randomized clinical trial to assess the efficacy of ulinastatin for postoperative pancreatitis following pancreaticoduodenectomy. J Surg Oncol 2008;98:309-13.